X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22024) 22024
Book / eBook (69) 69
Magazine Article (47) 47
Conference Proceeding (8) 8
Publication (7) 7
Book Chapter (6) 6
Dissertation (6) 6
Web Resource (5) 5
Book Review (4) 4
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15724) 15724
anti-bacterial agents - pharmacokinetics (9637) 9637
pharmacology & pharmacy (8211) 8211
anti-bacterial agents - administration & dosage (7534) 7534
anti-bacterial agents - therapeutic use (7530) 7530
male (7515) 7515
anti-bacterial agents - pharmacology (7177) 7177
female (7148) 7148
animals (6749) 6749
microbiology (5155) 5155
pharmacokinetics (5069) 5069
antibiotics (4528) 4528
microbial sensitivity tests (4512) 4512
adult (4051) 4051
infectious diseases (3984) 3984
middle aged (3739) 3739
aged (3090) 3090
anti-bacterial agents - adverse effects (2673) 2673
anti-bacterial agents - blood (2502) 2502
infections (2190) 2190
treatment outcome (2111) 2111
vancomycin (1783) 1783
anti-bacterial agents - chemistry (1781) 1781
bacterial infections - drug therapy (1676) 1676
dose-response relationship, drug (1676) 1676
analysis (1641) 1641
health aspects (1580) 1580
adolescent (1554) 1554
bacteria (1525) 1525
mice (1502) 1502
area under curve (1496) 1496
drug resistance, bacterial (1447) 1447
pharmacodynamics (1425) 1425
therapy (1420) 1420
veterinary sciences (1415) 1415
pharmacology (1369) 1369
aged, 80 and over (1326) 1326
resistance (1319) 1319
rats (1281) 1281
administration, oral (1275) 1275
child (1270) 1270
drug administration schedule (1259) 1259
half-life (1253) 1253
research (1225) 1225
infection (1222) 1222
time factors (1188) 1188
drug therapy (1174) 1174
efficacy (1159) 1159
in-vitro (1134) 1134
antibacterial agents (1123) 1123
pseudomonas-aeruginosa (1113) 1113
staphylococcus aureus - drug effects (1112) 1112
anti-bacterial agents - metabolism (1106) 1106
retrospective studies (1096) 1096
drug resistance (1078) 1078
antimicrobial agents (1068) 1068
staphylococcal infections - drug therapy (1063) 1063
bacteria - drug effects (1054) 1054
pneumonia (1043) 1043
drug interactions (1042) 1042
internal medicine (1040) 1040
drug therapy, combination (1017) 1017
aminoglycosides (985) 985
prospective studies (981) 981
medicine & public health (968) 968
kinetics (967) 967
ciprofloxacin (965) 965
dosage and administration (957) 957
young adult (947) 947
models, biological (936) 936
research article (935) 935
gentamicin (932) 932
drug resistance in microorganisms (931) 931
infectious disease (930) 930
care and treatment (911) 911
risk factors (892) 892
staphylococcus-aureus (889) 889
vancomycin - pharmacokinetics (879) 879
biological availability (870) 870
immunology (865) 865
escherichia-coli (858) 858
child, preschool (851) 851
pediatrics (847) 847
tissue distribution (847) 847
drugs (843) 843
critically-ill patients (826) 826
fluoroquinolones (816) 816
pseudomonas aeruginosa - drug effects (806) 806
infant (803) 803
vancomycin - administration & dosage (768) 768
susceptibility (760) 760
drug resistance, multiple, bacterial (753) 753
infant, newborn (752) 752
infusions, intravenous (750) 750
children (748) 748
resistant staphylococcus-aureus (742) 742
chromatography, high pressure liquid (729) 729
escherichia coli - drug effects (724) 724
antimicrobial resistance (721) 721
disease models, animal (717) 717
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (40) 40
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Credit Valley Hospital - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
May be requested (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - Pharmacy (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21055) 21055
Japanese (433) 433
French (262) 262
German (179) 179
Russian (179) 179
Spanish (163) 163
Chinese (61) 61
Italian (57) 57
Polish (32) 32
Czech (22) 22
Dutch (17) 17
Bulgarian (15) 15
Hungarian (12) 12
Danish (11) 11
Portuguese (9) 9
Romanian (8) 8
Swedish (7) 7
Norwegian (5) 5
Serbian (5) 5
Hebrew (4) 4
Finnish (3) 3
Turkish (3) 3
Korean (2) 2
Lithuanian (2) 2
Slovak (2) 2
Ukrainian (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacokinetics, ISSN 0312-5963, 09/2000, Volume 39, Issue 3, pp. 215 - 231
.... Pharmacokinetic studies provide differing data on renal function in obese... 
Beta adrenoceptor antagonists, pharmacokinetics | Bisoprolol, pharmacokinetics | Propranolol, pharmacokinetics | Gentamicin, pharmacokinetics | Dexfenfluramine, pharmacokinetics | Clinical pharmacokinetics | Nicotine, pharmacokinetics | Sotalol, pharmacokinetics | Antineoplastics, pharmacokinetics | Remifentanil, pharmacokinetics | Antihyperglycaemics, pharmacokinetics | Vecuronium bromide, pharmacokinetics | Theophylline, pharmacokinetics | Phenytoin, pharmacokinetics | Antibacterials, pharmacokinetics | Anaesthetics, pharmacokinetics | Doxorubicin, pharmacokinetics | Propofol, pharmacokinetics | Rocuronium bromide, pharmacokinetics | Anticonvulsants, pharmacokinetics | Carbamazepine, pharmacokinetics | Nebivolol, pharmacokinetics | Obesity | Sufentanil, pharmacokinetics | Vancomycin, pharmacokinetics | Anorectics, pharmacokinetics | Neuropsychotherapeutics, pharmacokinetics | Caffeine, pharmacokinetics | Interferon alpha, pharmacokinetics | Neuromuscular blocking agents, pharmacokinetics | Antifungals, pharmacokinetics | Cyclophosphamide, pharmacokinetics | Xanthines, pharmacokinetics | Ciprofloxacin, pharmacokinetics | General anaesthesia | Glibenclamide, pharmacokinetics | Labetalol, pharmacokinetics | Busulfan, pharmacokinetics | Glipizide, pharmacokinetics | Ifosfamide, pharmacokinetics | Lithium, pharmacokinetics | Opioids, pharmacokinetics | Carboplatin, pharmacokinetics | Phenazone, pharmacokinetics | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | LEAN BODY-MASS | VANCOMYCIN | METABOLISM | NORMAL VOLUNTEERS | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | PATIENT | CLINICAL PHARMACOKINETICS | SIGNIFICANT WEIGHT-REDUCTION | CREATININE CLEARANCE | DISPOSITION | Adrenergic beta-Antagonists - pharmacokinetics | Anesthetics - pharmacokinetics | Anticonvulsants - pharmacokinetics | Hypoglycemic Agents - pharmacokinetics | Obesity - drug therapy | Antifungal Agents - pharmacokinetics | Humans | Anti-Bacterial Agents - pharmacokinetics | Antineoplastic Agents - pharmacokinetics | Obesity - metabolism
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 2016, Volume 21, Issue 8, p. 991
... and antivirus, cytotoxic, immunomodulatory, and enzyme inhibitory effects, and pharmacokinetic properties. 
Bioactivity | Pharmacokinetics | Novel structures | Phenylethanoid glycosides | CISTANCHE-SALSA EXTRACT | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | novel structures | TANDEM MASS-SPECTROMETRY | CHEMISTRY, MULTIDISCIPLINARY | PERFORMANCE LIQUID-CHROMATOGRAPHY | phenylethanoid glycosides | VITRO ANTIINFLAMMATORY ACTIVITY | IN-VITRO | bioactivity | FORSYTHIA-SUSPENSA | METABOLITE P-TYROSOL | LC-MS/MS METHOD | pharmacokinetics | RAT PLASMA | Neuroprotective Agents - therapeutic use | Antioxidants - chemistry | Antiviral Agents - pharmacokinetics | Immunologic Factors - isolation & purification | Anti-Bacterial Agents - therapeutic use | Immunologic Factors - pharmacokinetics | Neuroprotective Agents - pharmacokinetics | Antiviral Agents - chemistry | Anti-Bacterial Agents - chemistry | Glycosides - isolation & purification | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - pharmacokinetics | Anti-Inflammatory Agents - isolation & purification | Drugs, Chinese Herbal - therapeutic use | Glycosides - chemistry | Immunologic Factors - chemistry | Plants, Medicinal - chemistry | Neuroprotective Agents - chemistry | Antiviral Agents - therapeutic use | Phenylethyl Alcohol - pharmacokinetics | Anti-Bacterial Agents - isolation & purification | Phenylethyl Alcohol - isolation & purification | Drugs, Chinese Herbal - pharmacokinetics | Antioxidants - therapeutic use | Anti-Inflammatory Agents - chemistry | Neuroprotective Agents - isolation & purification | Antioxidants - isolation & purification | Drugs, Chinese Herbal - chemistry | Anti-Bacterial Agents - pharmacokinetics | Glycosides - pharmacokinetics | Antioxidants - pharmacokinetics | Antiviral Agents - isolation & purification | Phenylethyl Alcohol - therapeutic use | Glycosides - therapeutic use | Immunologic Factors - therapeutic use | Phenylethyl Alcohol - chemistry
Journal Article
Journal Article
1978, Antibiotics and chemotherapy, ISBN 3805527527, Volume 25., xii, 320
Book
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2011, Volume 55, Issue 10, pp. 4619 - 4630
A pharmacokinetic-pharmacodynamic (PKPD) model that characterizes the full time course of time-kill curve experiments of antibacterial drugs was here evaluated in its capacity to predict the previously determined PK/PD indices. Six drugs... 
VITRO DYNAMIC-MODEL | STREPTOCOCCUS-PNEUMONIAE | PHARMACODYNAMIC MODEL | POPULATION PHARMACOKINETICS | PSEUDOMONAS-AERUGINOSA | ADAPTIVE RESISTANCE | IN-VIVO | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MONTE-CARLO SIMULATIONS | AMINOGLYCOSIDE ANTIBIOTICS | RESPIRATORY-TRACT INFECTIONS | Fluoroquinolones | Aza Compounds - pharmacokinetics | Area Under Curve | Erythromycin - pharmacology | Escherichia coli - drug effects | Humans | Cefuroxime - pharmacology | Aza Compounds - pharmacology | Quinolines - pharmacology | Microbial Sensitivity Tests | Quinolines - pharmacokinetics | Anti-Bacterial Agents - therapeutic use | Gentamicins - pharmacology | Computer Simulation | Vancomycin - pharmacology | Streptococcus pyogenes - drug effects | Gentamicins - pharmacokinetics | Penicillin G - pharmacology | Erythromycin - pharmacokinetics | Cefuroxime - pharmacokinetics | Vancomycin - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Anti-Bacterial Agents - administration & dosage | Penicillin G - pharmacokinetics | Drugs | Subpopulations | Pharmacodynamics | Gentamicin | Benzylpenicillin | Erythromycin | Moxifloxacin | Regression analysis | Vancomycin | Drug development | Cefuroxime | Antibiotics | Minimum inhibitory concentration | Models | Pharmacokinetics | Experimental Therapeutics
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 8/2013, Volume 57, Issue 4, pp. 524 - 531
Journal Article
Critical Care Medicine, ISSN 0090-3493, 05/2012, Volume 40, Issue 5, pp. 1523 - 1528
Journal Article
Diagnostic Microbiology & Infectious Disease, ISSN 0732-8893, 2012, Volume 74, Issue 3, pp. 213 - 223
Journal Article